DeltaーFly Pharma株式会社 · Pharmaceutical · FY ends Mar
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | 江島 淸 | 832,000 | 6.32% | — | — |
| 2 | BNYM SA/NV FOR BNYM FOR BNY GCM CLIENT ACCOUNTS M LSCB RD | 455,600 | 3.46% | — | — |
| 3 | 日本ケミファ株式会社 | 430,300 | 3.27% | — | — |
| 4 | 宮崎 大輝 | 358,600 | 2.72% | — | — |
| 5 | 楽天証券株式会社共有口 | 275,800 | 2.09% | — | — |
| 6 | 宮崎 羅貴 | 260,000 | 1.97% | — | — |
| 7 | モルガン・スタンレーMUFG証券株式会社 | 214,200 | 1.63% | — | — |
| 8 | MACQUARIE BANK LIMITED DBU AC | 174,900 | 1.33% | — | — |
| 9 | 白川 貴教 | 165,000 | 1.25% | — | — |
| 10 | Sanyo Chemical Industries Co., Ltd. | 150,000 | 1.14% | — | — |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| 江島 淸 | President & Representative Director | 832,000 | — | — |
| 飯塚 健蔵 | Director | 85,000 | — | — |
| 黒滝 健一 | Director | — | — | — |
| 岸井 幸生 | Director | — | — | — |
| 小南 欽一郎 | Director | — | — | — |
| 谷口 明史 | Director | — | — | — |
| 前田 真明 | Full-time Audit & Supervisory Board Member | — | — | — |
| 木村 正弥 | Audit & Supervisory Board Member | 15,000 | — | — |
| 山本 昇平 | Audit & Supervisory Board Member | — | — | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Mar 2026 | — | ¥-140.45 | — | — | 13,175,000 |
| FY ending Mar 2025 | — | ¥-195.58 | — | — | 9,729,900 |
| FY ending Mar 2024 | — | ¥-198.78 | — | — | 8,229,900 |
| FY ending Mar 2023 | — | ¥-234.51 | — | — | 6,369,600 |
| FY ending Mar 2022 | — | ¥-178.58 | — | — | 5,419,600 |
| FY ending Mar 2021 | — | ¥-187.34 | — | — | 5,314,600 |
| FY ending Mar 2020 | — | ¥-348.32 | — | — | 4,504,600 |